1st International Caparica Conference on Prescriptomics and Precision Medicine 2024

11th – 13th May 2024 | Caparica | Portugal

Oral Speakers

Sabina Passamonti, PhD

University of Trieste, Department of Life Sciences (Italy)

Nanoscale Bilirubin Analysis in Translational Research and Precision Medicine by the Recombinant Protein HUG

Ekaterina Ushakova, PhD

Department of Immune Biotechnology, NRC Institute of Immunology FMBA of Russia, Moscow (Russian Federation)

Comparison of immunogenicity and effectiveness of multi-antigen and neo-antigen personalized cancer vaccines.

Masanori Hatakeyama, PhD

Microbial Chemistry Research Foundation, The University of Tokyo (Japan)

The multifaceted role of the Helicobacter pylori CagA oncoprotein in the development of gastric cancer

Jacob Joseph, PhD

Brown University (USA)

Developing Precision Medicine Approaches for a Major Unmet Need: Heart Failure with Preserved Ejection Fraction

Chiara Maria Mazzanti, PhD

Fondazione Pisana per la Scienza (Italy)

Improving Glioblastoma Patient Stratification: Integrating Innovative In Vitro Pre-Clinical Models and Advanced Imaging Techniques

Maria Frias, PhD

St. Francis College (USA)

Regulation of mTOR by phosphatidic acid

Michael Sherman, PhD

Ariel University (Israel)

Acquired resistance to doxorubicin in cancer cells involves generation of topoisomerase-guided mutations that reduces the chances of DNA breaks: Strategies for treatment of doxorubicin resistant cancers.

Anna Bielecka Wajdman, PhD

Department of Pharmacology, Medical University of Silesia, Katowice (Poland)

Targeting glycosylation and metabolic signatures as elements of the therapy against Glioblastoma multiforme

Paola Betancur, PhD

University of California, San Francisco (USA)

The genome in precision medicine: Lessons to be learned from a genomic insertion/deletion contributing to breast tumorigenesis

Daniele Lo Re, PhD

University of Granada (Spain)

Peptide−Platinum(IV) conjugation minimizes the negative effect of chemotherapy through low accumulation in the tumour microenvironment

Stavroula Baritaki, PhD

Medical School University of Crete (Greece)

The transcriptional landscape and prognostic potential of long non-coding RNA signatures in pancreatic cancer stem cells.

Joseph Izzo, PhD

University at Buffalo (USA)

Maintenance of long-term blood pressure control and vascular health by low-dose amiloride- based therapy in hyperaldosteronism

Maria Paola Costi, PhD

University of Modena and Reggio Emilia (Italy)

Folic Acid-Peptide Conjugates are selectively internalized and target Thymidylate Synthase Dimer Interface in cancer cells

Cristina Al-Khalili Szigyarto, PhD

Royal Institute of Technology – KTH (Sweden)

Therapy Responsive Blood Biomarkers for Duchenne Muscular Dystrophy

Sunil Shankar Adav, PhD

Nanyang Technological University (Singapore)

Unlocking Insights from Human Hair in Precision Medicine: Harnessing the Power of ‘Omics-Based Approaches

Andriy Marusyk, PhD

Moffitt Cancer Center (USA)

Impact of microenvironmental therapy sheltering on the evolution of resistance to targeted therapies in lung cancers

Yasser Riazalhosseini, PhD

McGill University (Canada)

Unraveling the biology of aggressive tumor phenotypes using integrated spatial genomics and transcriptomics

Aleksandra Karolak, PhD

Moffitt Cancer Center and Research Institute (USA)

Transformer Graph Variational Autoencoder for De Novo Drug Design

Bin Zhang, PhD

Northwestern University (USA)

Metabolic reprogramming of antitumor CD8 + T cells for adoptive cellular therapy

Gamze Gürsoy, PhD

Columbia University (USA)

Xin Lai, PhD

Faculty of Medicine and Health Technology, Tampere University (Finland)

A disease network-based deep learning approach for characterizing melanoma

Jorge González, PhD

Universidad de Antofagasta (Chile)

Role of proteomics in predicting virulence and pathogenicity of parasitic infection

Ugo Chianese, PhD

Università degli Studi della Campania Luigi Vanvitelli (Italy)

Mor Moskovitz, PhD

Davidoff Cancer Center, Beilinson, Petah-Tikva (Israel)